Hello! You're looking at a policy document report on Overton

We track government policy, guidelines, think tank research, working papers and more to help our customers see the impact and influence of their work. Are you interested in seeing what information we have to offer? Request a free trial to our platform.

If you fund, produce or manage research or work to influence policy, we'd love to talk. Learn more on our homepage.

Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline

Flag for USA American Society of Clinical Oncology on October 5th 2022

Topics in this document

Related SDGs

SDG 3: Good Health and Well-being ...
SDG 3: Good Health and Well-being

Target 3.4

Reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being

Target 3.b

Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all

Cites research funded by

2 MRC 1 FAPESP 1 CNPq 1 FAPERJ 1 Ministério da Ciência, Tecnologia e Inovação 1 Fundação de Amparo à Pesquisa do Estado de São Paulo 1 Conselho Nacional de Desenvolvimento Científico e Tecnológico 1 Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro 1 Janssen Research & Development, LLC 3 Johnson and Johnson 3 Auris Health 3 Janssen Research and Development 4 NIH CTSA 2 Millennium Pharmaceuticals, Inc. 1 National Heart, Lung, and Blood Institute 1 Genentech, Inc. 1 National Institute of Allergy and Infectious Diseases 1 University of Minnesota 1 Kiadis Pharma 1 Blue Cross and Blue Shield Association 1 Therakos 1 Celgene Corporation 1 GlaxoSmithKline 1 The Leukemia & Lymphoma Society 1 Otsuka America Pharmaceutical, Inc. 1 WellPoint 3 Onyx Pharmaceuticals 1 Terumo BCT 1 Osiris Therapeutics, Inc. 1 Genzyme Corporation 1 Tarix Pharmaceuticals 1 Be The Match Foundation 1 Office of Naval Research 1 National Cancer Institute 1 St. Baldrick's Foundation 1 University of Utah 1 StemCyte, A Global Cord Blood Therapeutics Co 1 Ariad 1 Fred Hutchinson Cancer Research Center 1 NCI 1 Actinium Pharmaceuticals 1 Allos Therapeutics, Inc. 1 Amgen, Inc. 1 Chimerix, Inc. 1 Fresenius-Biotech North America, Inc. 1 Gamida Cell Teva Joint Venture Ltd. 1 Gentium SpA 1 Health Research, Inc. Roswell Park Cancer Institute 1 HistoGenetics, Inc. 1 Incyte Corporation ... and others

Citations

Cited by 19 other policy documents (all of them are from other policy sources)
 

Recognized names mentioned in this document

Overton only tracks names from certain institutions. Names must have been cited in at least one policy document and their corresponding affiliation has to be found nearby - you can find more details on the help page.

Caitlin Costello at University of California, San Diego
On page 38 (or quick view this section)